Log in
Enquire now
‌

US Patent 9346792 3,5-diaminopyrazole kinase inhibitors

Patent 9346792 was granted and assigned to Axikin Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Axikin Pharmaceuticals
Axikin Pharmaceuticals
0
Current Assignee
Axikin Pharmaceuticals
Axikin Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
93467920
Patent Inventor Names
Garrett Thomas Potter0
Tai Wei Ly0
Erik Dean Raaum0
Date of Patent
May 24, 2016
0
Patent Application Number
145740070
Date Filed
December 17, 2014
0
Patent Primary Examiner
‌
Samantha Shterengarts
0
Patent abstract

Provided herein are 3,5-diaminopyrazoles, for example, compounds of Formula IA, that are useful for modulating regulated-in-COPD kinase activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a RC kinase-mediated disorder, disease, or condition.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9346792 3,5-diaminopyrazole kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.